Lymphology    淋巴学
:: Home   :: Contact us   :: Feedback   :: Site Map          
 
Instructions for authors 

    U. S. Chinese Journal of Lymphology and Oncology is an English international academic periodical owned by the American-Chinese Medical Association and published by the college of Medicine, Shandong University, PRC. The JOURNAL has been accepted by the General Administration of Press and Publishing. PRC to be issued in China and the word. Its editorial policies are the responsibility of the Editor-in-Chief, the Associate Editors, and the Editorial Board.
The JOURNAL publishes papers based on original, previously unpublished researche of the lymphatic system and oncology, including etiology, pathology and the treatment of any related diseases. Manuscripts may be submitted for consideration as Regular Papers or Accelerated Publications. The JOURNAL also publishes some Reviews, and some medical information. Authors are urged to keep the length of Regular Papers to six printed pages or less. Accelerated Publications can be no longer than four printed pages.
    There is a per-page charge for all published manuscripts, currently $45 /printed page (pre paid). Author unable to pay page charges may apply at the time of submission for a waiver of page charges. Applications must be endorsed by a senior institutional official.
    As a condition of publication, all authors must transfer copyright to the American Chinese Medical Association. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission and that the final version of the manuscript has been seen and approved by all authors.
All manuscripts submitted to the JOUNAL are reviewed critically. It is the responsibility of the Editor-in-chief, the Associate Editors, and the Editorial Board to determine their suitability for publication. After receipt of a manuscript by the Editor, the submission is sent to an Associate Editor who usually assigns it to a member of the Editorial Board. The Board member then makes a definitive recommendation for acceptance, revision, or declination based on the scientific merit and technical quality of the studies reported.
    The primary criteria for judging the acceptability of a manuscript are its originality and scientific importance. Manuscripts judged lacking in these respects will be declined, even if the experimental work appears technically sound. This policy permits declination of a manuscript solely on the Editorial Board’s judgment that the studies reported are not sufficiently original or important to merit publication in the JOURNAL. If a manuscript is not recommended by the reviewer for publication, the Associate. Editor may decline it without further review.
    All Board members and referees who review a manuscript remain unknown to the authors. Every manuscript is treated by the Editors and referees as privileged information, and they are instructed exclude themselves from review of any manuscript that might involve a conflict of interest or the appearance thereof.

Instructions to Authors

All submitted manuscripts should contain original research not previously published and not under consideration for publication elsewhere. Papers must be written in English.


How to Submit

Authors are required to submit manuscripts electronically using the Online Submission at http://www. to lymph@sdu.edu.cn by email, or by mail with disk.

 

Organization of the Manuscript
1. Printed on 21.0 × 29.7 high-quality paper
2. Double spacing throughout
3. One-inch margins
4. Text typed in a front size of at least ten point
5. Manuscript is to be arranged in the following order:
(a) title, author(s), and complete name(s) of institution(s)
(b) summary
(c) introduction
(d) experimental procedures
(e) results
(f) discussion
(g) references
(h) footnotes
(i) figure legends
(j) tables
(k) figures
6. Number all papers including figures with the title page as page 1.
7. Indicate the suggested location in the text of each figure and table.

Title
* as short and informative as possible
* should not contain non-standard acronyms or abbreviations
* should not exceed two printed lines

Title Page
* contain names of all authors and complete mailing addresses of responsible author
* to whom all correspondence about the manuscript, including proofs, will be sent:
(a) name
(b) telephone and fax numbers
(c) email address

Summary
* should succinctly and clearly describe the major findings reported in the manuscript
* must not exceed 300 words nor contain abbreviations or specialized terms
* should be understandable in itself, since it is frequently used as an abstract

Introduction
* Presents the purpose of the studies reported and their relationship to earlier work in the field
* Should not be an extensive review of the literature nor exceed three typed pages generally

Experimental Procedures
* brief but sufficiently complete to permit a qualified reader to repeat the experiments
* only truly new procedures should be described in detail
* cite previously published procedures in References
* modifications of previously published procedures not given in detail except when necessary to repeat the work

Results
* presented in figures and tables
* some results not requiring documentation given solely in the text
* extensive discussion show not be included in the Results section

Discussion
* concise (usually less than four typed pages)
* focused on the interpretation of the results rather than a repetition of the Results section
* Errors in a published paper will be corrected in the JOURNAL in “Additions and Corrections”

References
* cited in text by number rather than author and date
* numbered consecutively in the order of appearance in the manuscript
* References for journals and books should be in the following styles:
1. Magari S, Fujikawa K, Mizutani Y, et al. Morphological studies on liver lymphaties. Lymphology. 1979, 12:14-17
2. Samboo RJ, Fritsch EF, Maniatis T. Molecular cloning a laboratory manual. Second edition. New York: Cold spring Harbor, 1998. 101-109.


Footnotes
* used to cite manuscript in preparation, unpublished observations and personal communications
* all abbreviations used in the text must be defined in a single footnote inserted in the text immediately after the first abbreviation is cited.
* the abbreviations of some important biochemical compounds, e.g. ATP, DNA, RNA, need not be defined.

Tables
* the number of tables should be kept to a minimum.
* very complex or large tables should be submitted as a figure.
* tables should have titles and sufficient experimental detail in a legend immediately. following the title to be understandable without reference to be the text.
* each column in a table must have a heading, and abbreviation, when necessary, should be defined in the legend


Figures
* should have titles and explanatory legends containing sufficient detail to make the figure easily understood.
* all legends should be printed consecutively in a separate section of the manuscript.
* numbers, letters, and symbols used in multi-paneled figures must be consistent.
* the abscissa and ordinate should be clearly labeled with appropriately sized type, and units of measurement must be given.
* scales for plotting the data should be marked by short index lines, but every index line need not be number.
* use standard symbols found in MS Word with symbols and curves identified in the legend and not on the figure.
* indicate the figure number on the front of each figure.


 

 

 
        电话:086-0531-88382573
               鲁ICP备07000689号
Copyright ⓒ 2007 [Journal of Lymphology and Oncology]. All rights reserved